TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,780,752 | -3.8% | 244,393 | -2.3% | 0.01% | -14.3% |
| Q2 2023 | $3,928,104 | -0.7% | 250,038 | +4.1% | 0.01% | 0.0% |
| Q1 2023 | $3,956,576 | +52.7% | 240,083 | +44.5% | 0.01% | +40.0% |
| Q4 2022 | $2,591,152 | +153.5% | 166,099 | +110.7% | 0.01% | +150.0% |
| Q3 2022 | $1,022,000 | -14.8% | 78,833 | -7.6% | 0.00% | 0.0% |
| Q2 2022 | $1,199,000 | +4.0% | 85,355 | +6.0% | 0.00% | 0.0% |
| Q1 2022 | $1,153,000 | +1.9% | 80,531 | -2.9% | 0.00% | 0.0% |
| Q4 2021 | $1,131,000 | -26.2% | 82,969 | -11.3% | 0.00% | -33.3% |
| Q3 2021 | $1,532,000 | -4.8% | 93,546 | -2.2% | 0.00% | 0.0% |
| Q2 2021 | $1,609,000 | +21.1% | 95,611 | +31.4% | 0.00% | +50.0% |
| Q1 2021 | $1,329,000 | -13.4% | 72,756 | -13.7% | 0.00% | -33.3% |
| Q4 2020 | $1,535,000 | -12.1% | 84,353 | -13.8% | 0.00% | -25.0% |
| Q3 2020 | $1,747,000 | -17.7% | 97,894 | -17.3% | 0.00% | -20.0% |
| Q2 2020 | $2,123,000 | +3.2% | 118,422 | -12.7% | 0.01% | 0.0% |
| Q1 2020 | $2,058,000 | -31.4% | 135,583 | -10.8% | 0.01% | -16.7% |
| Q4 2019 | $3,000,000 | +56.5% | 152,051 | +36.5% | 0.01% | -81.8% |
| Q3 2019 | $1,917,000 | +2.2% | 111,414 | +5.1% | 0.03% | +3.1% |
| Q2 2019 | $1,876,000 | +0.7% | 106,016 | +15.9% | 0.03% | -3.0% |
| Q1 2019 | $1,863,000 | +77.6% | 91,453 | +46.7% | 0.03% | +57.1% |
| Q4 2018 | $1,049,000 | – | 62,348 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |